Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH

被引：0

作者：

Geh, Daniel ^{[1
]}

Gil, Erik Ramon ^{[1
]}

Laszczewska, Maja ^{[1
]}

Collins, Amy ^{[1
]}

Luli, Saimir ^{[1
]}

Cameron, Rainie ^{[1
]}

Oakley, Fiona ^{[1
]}

Leslie, Jack ^{[1
]}

Reeves, Helen Louise ^{[2
,3
]}

Mann, Derek A. ^{[1
]}

机构：

[1] Newcastle Univ, Newcastle Fibrosis Res Grp, Biosci Inst, Fac Med Sci, Newcastle, NSW, Australia

[2] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle, NSW, Australia

[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp Hepatopancreatobiliary Multidiscipli, Newcastle, NSW, Australia

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-234

引用

页码：S538 / S539

页数：2

共 50 条

[21] Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
Sydor, Svenja
Best, Jan
Messerschmidt, Insa
Manka, Paul
Vilchez-Vargas, Ramiro
Brodesser, Susanne
Lucas, Christina
Wegehaupt, Annemarie
Wenning, Chiara
Assmuth, Sophia
Hohenester, Simon
Link, Alexander
Faber, Klaas Nico
Moshage, Han
Javier Cubero, Francisco
Friedman, Scott L.
Gerken, Guido
Trauner, Michael
Canbay, Ali
Bechmann, Lars P.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00131
[22] Canagliflozin prevents development of hepatocellular carcinoma (HCC) from non-alcoholic steatohepatitis (NASH) in a novel mouse model of NASH-HCC under diabetic state
Jojima, T.
Kishi, H.
Iijima, T.
Usui, I.
Aso, Y.
DIABETOLOGIA, 2018, 61 : S319 - S319
[23] Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity
Dudek, Michael
Tacke, Frank
GUT, 2022, 71 (10) : 1937 - 1938
[24] Lack of Osteopontin promotes non-alcoholic steatohepatitis (NASH) and fibrosis, but protects against hepatocellular carcinoma (HCC) progression and mortality in a NASH-HCC mouse model
Nardo, A. D.
Gruen, N. G.
Zeyda, M.
Oberhuber, G.
Dumanic, M.
Helbich, T.
Stulnig, T. M.
JOURNAL OF HEPATOLOGY, 2018, 68 : S680 - S681
[25] Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Ge, Chenxu
Tan, Jun
Dai, Xianling
Kuang, Qin
Zhong, Shaoyu
Lai, Lili
Yi, Chao
Sun, Yan
Luo, Jing
Zhang, Chufeng
Zhu, Liancai
Wang, Bochu
Xu, Minxuan
NATURE COMMUNICATIONS, 2022, 13 (01)
[26] Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Chenxu Ge
Jun Tan
Xianling Dai
Qin Kuang
Shaoyu Zhong
Lili Lai
Chao Yi
Yan Sun
Jing Luo
Chufeng Zhang
Liancai Zhu
Bochu Wang
Minxuan Xu
Nature Communications, 13
[27] The significance of PGE2 accumulation by 15-PGDHdepletion in NASH-HCC development
Hu, Xichen
Baba, Hideo
Ishimoto, Takatsugu
Yasuda, Tadahito
CANCER SCIENCE, 2023, 114 : 815 - 815
[28] HEPATOCYTE TAZ PROMOTES NASH-HCC THROUGH CYBB-MEDIATED DNA DAMAGE
Wang, Xiaobo
Zhu, Changyu
Pajvani, Utpal B.
Schwabe, Robert F.
Tabas, Ira
HEPATOLOGY, 2020, 72 : 330A - 331A
[29] A maternal high-fat diet induces fetal origins of NASH-HCC in mice
Takao Takiyama
Toshihiro Sera
Masanori Nakamura
Masato Hoshino
Kentaro Uesugi
Shin-ichi Horike
Makiko Meguro-Horike
Ryoichi Bessho
Yuri Takiyama
Hiroya Kitsunai
Yasutaka Takeda
Kazuki Sawamoto
Naoto Yagi
Yuji Nishikawa
Yumi Takiyama
Scientific Reports, 12
[30] FUNCTIONAL DEFECTS IN MACROPHAGES ACCELERATE NASH-HCC IN MICE LACKING TREM2
Ganguly, Souradipta
German, Aleman
Rosenthal, Brin
Khader, Naser
Irfan, Asra
Liu, Jacey J.
Castorena, Nathalia
Soroosh, Pejman
Kisseleva, Tatiana
Brenner, David A.
Dhar, Debanjan
GASTROENTEROLOGY, 2022, 162 (07) : S1141 - S1141

← 1 2 3 4 5 →